Related Items

Bridge Project Events 2014

Symposium: Targeting Mutant IDH1 in Malignant Gliomas

May 22, 2014

Bridge to Success

Targeting Mutant IDH1 in Malignant Gliomas, a collaboration between Matthew Vander Heiden of the Koch Institute, William Kaelin of the Dana-Farber Cancer Institute, and Daniel Cahill of Massachusetts General Hospital